Désirée Lötzke1, Peter Heusser2, Arndt Büssing1. 1. Quality of Life, Spirituality and Coping, Institute of Integrative Medicine, University of Witten/Herdecke, 58313 Herdecke, Germany. 2. Theory of Medicine, Integrative and Anthroposophic Medicine, Institute of Integrative Medicine, University of Witten/Herdecke, 58313 Herdecke, Germany.
Abstract
BACKGROUND: Eurythmy therapy is a movement therapy of anthroposophic medicine that can have effects on a person's physical body, spirit, and soul. OBJECTIVE: The aim of this publication was to update and summarize the relevant literature on the effectiveness of eurythmy in a therapeutic context since 2008. SEARCH STRATEGY: Different databases like PubMed, MEDPILOT, Research Gate, The Cochrane Library, DIMDI, Arthe and also the journal databases Der Merkurstab and the European Journal of Integrative Medicine were searched for prospective and retrospective clinical trials in German or English language. INCLUSION CRITERIA: There were no limitations for indication, considered outcome or age of participants. DATA EXTRACTION AND ANALYSIS: Studies were evaluated with regard to their description of the assembly process and treatment, adequate reporting of follow-ups, and equality of comparison groups in controlled trials. RESULTS: Eleven studies met the inclusion criteria. These included two single-arm, non-controlled pilot studies, two publications on the same non-randomized controlled trial and one case study; six further studies referred to a prospective cohort study, the Anthroposophic Medicine Outcome Study. Most of these studies described positives treatment effects with varying effect sizes. The studies were heterogynous according to the indications, age groups, study design and measured outcome. The methodological quality of the studies varied considerably. There were no clear improvements since 2008, when the recommendations were published in the first review. CONCLUSION: Eurythmy seems to be a beneficial add-on in a therapeutic context that can improve the health conditions of affected persons. More methodologically sound studies are needed to substantiate this positive impression.
BACKGROUND: Eurythmy therapy is a movement therapy of anthroposophic medicine that can have effects on a person's physical body, spirit, and soul. OBJECTIVE: The aim of this publication was to update and summarize the relevant literature on the effectiveness of eurythmy in a therapeutic context since 2008. SEARCH STRATEGY: Different databases like PubMed, MEDPILOT, Research Gate, The Cochrane Library, DIMDI, Arthe and also the journal databases Der Merkurstab and the European Journal of Integrative Medicine were searched for prospective and retrospective clinical trials in German or English language. INCLUSION CRITERIA: There were no limitations for indication, considered outcome or age of participants. DATA EXTRACTION AND ANALYSIS: Studies were evaluated with regard to their description of the assembly process and treatment, adequate reporting of follow-ups, and equality of comparison groups in controlled trials. RESULTS: Eleven studies met the inclusion criteria. These included two single-arm, non-controlled pilot studies, two publications on the same non-randomized controlled trial and one case study; six further studies referred to a prospective cohort study, the Anthroposophic Medicine Outcome Study. Most of these studies described positives treatment effects with varying effect sizes. The studies were heterogynous according to the indications, age groups, study design and measured outcome. The methodological quality of the studies varied considerably. There were no clear improvements since 2008, when the recommendations were published in the first review. CONCLUSION: Eurythmy seems to be a beneficial add-on in a therapeutic context that can improve the health conditions of affected persons. More methodologically sound studies are needed to substantiate this positive impression.
Authors: G S Kienle; E Ben-Arye; B Berger; C Cuadrado Nahum; T Falkenberg; G Kapócs; H Kiene; D Martin; U Wolf; H Szöke Journal: Evid Based Complement Alternat Med Date: 2019-11-12 Impact factor: 2.629